Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Mexico / NCT06877884
Recruiting Observational

A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data

NCT06877884 · tracked via the Priya Life Science Mexico tracker
Sponsor
N-Power Medicine
Phase
Observational
Started
2022-08-01
Last updated
2025-10-20

Condition(s) studied

Cancer

Study summary

This is an observational registry for patients at participating oncology centers. The data collection includes but is not limited to baseline variables, treatments given and outcome data. Patient surveys are also included. The aim of the study is to generate rich and standardized data for patients and to help enable more patients participate in clinical trials and contribute to research and development.

Eligibility

Sex
ALL
Min age
18 Years
Max age
120 Years
Healthy volunteers
Accepted
Inclusion Criteria: Be a patient at a site (oncology) participating in the Registry Be at least 18 years old Be able and willing to provide signed informed consent Exclusion Criteria: Prisoners/imprisonment at time of screening for eligibility Patients who cannot consent without utilization of a legally authorized representative

Primary outcome measure(s)

  • Treatment Effectiveness - Time to treatment discontinuation — This is an open-ended registry where data will be collected, analysed and presented regularly over time.
    Effectiveness outcomes of treatments used in routine clinical care (such as for instance time to treatment discontinuation ) will be captured

Trial sites (7)

FacilityCityRegionStatus
Pacific Cancer Care Monterey California Recruiting
Bayhealth Cancer Center-Kent Dover Delaware Recruiting
Bayhealth Cancer Center- Sussex Milford Delaware Recruiting
Northwest Oncology & Hematology Elk Grove Village Illinois Recruiting
New Mexico Oncology Hematology Consultants Albuquerque New Mexico Recruiting
Lankenau Medical Center Paoli Pennsylvania Recruiting
Oncology Consultants, P.A. Houston Texas Recruiting

More N-Power Medicine trials in Mexico

Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer Recruiting
An External Control Arm Study in Non-Small Cell Lung Cancer Recruiting

Other trials for the same condition

Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer Recruiting
A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study Recruiting
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab Enrolling by invitation
Effects of Oncological Treatment During Pregnancy on Mother and Child Recruiting
Cancer Prevention for Young Rural Adults Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06877884 on ClinicalTrials.gov ↗ ← All trials in Mexico